Starting on:
Jul 29, 2021
Ending on:
Jul 29, 2021
Moderator(s):
Venue:
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
Jul 29, 2021
Ending on:
Jul 29, 2021
Moderator(s):
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
JOURNAL CLUB - 29/07/2021
Starting on:
Jul 29, 2021 8:00 AM
Jul 29, 2021 8:00 AM
Ending on:
Jul 29, 2021 9:30 AM
Jul 29, 2021 9:30 AM
Venue:
THE KAREN HOSPITAL
THE KAREN HOSPITAL
Description
Antithrombotic therapy in patients with heart failure in sinus rhythm
Objectives
- Heart failure (HF) represents a major and growing public health problem because of its prevalence, incidence, morbidity, mortality, and economic costs. The prevalence of HF is 2% to 3% of the general population.
- Although several therapies (eg, β-blockers, angiotensin-converting enzyme [ACE] inhibitors, and cardiac resynchronization therapy) have been proven effective in improving HF outcomes, many unanswered questions about optimal treatment remain.
- Observational data suggest that patients with HF have an increased venous thromboembolism (VTE) risk (deep venous thromboembolism [DVT], pulmonary embolism [PE], peripheral arterial thromboembolism, and stroke).
Presenters
-
Dr.
JANE WAVINYA
Medical Officer
THE KAREN HOSPITAL -
Dr.
George Otieno
Medical Officer
THE KAREN HOSPITAL